DNTH
Magenta Therapeutics Inc Earnings Dividend
$89.29
Earnings Summary
Revenue | $0.28Mn |
Net Profits | $97.91Mn |
Net Profit Margins | 34473.59% |
Magenta Therapeutics Inc’s revenue fell -78.58% since last year same period to $0.28Mn in the Q4 2025. On a quarterly growth basis, Magenta Therapeutics Inc has generated -28.28% fall in its revenue since last 3-months.
Magenta Therapeutics Inc’s net profit jumped 444.25% since last year same period to $97.91Mn in the Q4 2025. On a quarterly growth basis, Magenta Therapeutics Inc has generated 366.3% jump in its net profits since last 3-months.
Magenta Therapeutics Inc’s net profit margin jumped 1707.31% since last year same period to 34473.59% in the Q4 2025. On a quarterly growth basis, Magenta Therapeutics Inc has generated 471.32% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.03 |
EPS Estimate Current Year | -1.03 |
Magenta Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.03 - a -87.53% fall from last quarter’s estimates.
Magenta Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.03.
Key Ratios
Earning Per Share (EPS) | -1.43 |
Magenta Therapeutics Inc’s earning per share (EPS) fell -76.54% since last year same period to -1.43 in the Q4 2025. This indicates that the Magenta Therapeutics Inc has generated -76.54% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-05 | -0.55 | -0.97 | -76.36% |
2025-08-07 | -0.53 | -0.88 | -66.04% |
2026-03-09 | -1.03 | -1.43 | -38.65% |
2025-05-12 | -0.71 | -0.82 | -15.49% |
